Stuart Bloom

8.5k total citations · 1 hit paper
114 papers, 4.4k citations indexed

About

Stuart Bloom is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Stuart Bloom has authored 114 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Genetics, 42 papers in Epidemiology and 36 papers in Surgery. Recurrent topics in Stuart Bloom's work include Inflammatory Bowel Disease (69 papers), Microscopic Colitis (32 papers) and Helicobacter pylori-related gastroenterology studies (11 papers). Stuart Bloom is often cited by papers focused on Inflammatory Bowel Disease (69 papers), Microscopic Colitis (32 papers) and Helicobacter pylori-related gastroenterology studies (11 papers). Stuart Bloom collaborates with scholars based in United Kingdom, United States and Italy. Stuart Bloom's co-authors include Anthony W. Segal, Daniel JB Marks, Farooq Rahman, Alastair Windsor, Marco Novelli, Ian Arnott, Tariq Ahmad, Jack Satsangi, Craig Mowat and Timothy R. Orchard and has published in prestigious journals such as The Lancet, The Journal of Experimental Medicine and Gastroenterology.

In The Last Decade

Stuart Bloom

108 papers receiving 4.3k citations

Hit Papers

Guidelines for the management of inflammatory bowel disea... 2011 2026 2016 2021 2011 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Guidelines for the management of inflammatory bowel disease in adults
    2011 1.0k citations Craig Mowat, Ian Arnott et al. Gut profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stuart Bloom United Kingdom 27 2.4k 1.6k 1.3k 1.2k 583 114 4.4k
Kim L. Isaacs United States 29 2.3k 0.9× 1.5k 1.0× 1.3k 1.0× 654 0.6× 521 0.9× 95 3.9k
Graham Radford‐Smith Australia 34 2.0k 0.8× 1.4k 0.9× 1.0k 0.8× 733 0.6× 1.0k 1.7× 99 4.0k
Dominik Bettenworth Germany 29 3.3k 1.4× 2.4k 1.5× 1.7k 1.3× 654 0.6× 474 0.8× 103 5.0k
Christian Maaser Germany 41 2.7k 1.1× 2.1k 1.3× 1.8k 1.5× 1.1k 0.9× 665 1.1× 117 5.6k
Mark Löwenberg Netherlands 36 2.9k 1.2× 2.2k 1.4× 1.1k 0.9× 1.0k 0.9× 989 1.7× 166 4.9k
Eugeni Domènech Spain 36 2.5k 1.0× 2.2k 1.4× 1.2k 1.0× 598 0.5× 329 0.6× 222 4.0k
Charlie W. Lees United Kingdom 29 2.5k 1.0× 1.7k 1.1× 1.0k 0.8× 752 0.6× 813 1.4× 133 4.0k
Mariangela Allocca Italy 33 2.0k 0.8× 1.6k 1.0× 1.1k 0.8× 453 0.4× 279 0.5× 177 3.3k
Timothy R. Orchard United Kingdom 24 2.7k 1.1× 2.0k 1.2× 1.1k 0.9× 761 0.6× 538 0.9× 51 4.0k
Gwo‐Tzer Ho United Kingdom 29 2.5k 1.0× 1.8k 1.1× 1.1k 0.8× 781 0.7× 747 1.3× 65 3.9k

Countries citing papers authored by Stuart Bloom

Since Specialization
Citations

This map shows the geographic impact of Stuart Bloom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Bloom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Bloom more than expected).

Fields of papers citing papers by Stuart Bloom

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart Bloom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Bloom. The network helps show where Stuart Bloom may publish in the future.

Co-authorship network of co-authors of Stuart Bloom

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart Bloom. A scholar is included among the top collaborators of Stuart Bloom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart Bloom. Stuart Bloom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fragkos, Konstantinos C., Ana Lisboa, Kate Simpson, et al.. (2023). Two-year real-world outcome data from a single tertiary centre shows reduced ustekinumab persistence in a non-bio-naïve Crohn’s disease cohort with penetrating disease, -ostomies and sarcopenia. Therapeutic Advances in Chronic Disease. 14. 384237648–384237648. 1 indexed citations
2.
3.
Horsfall, Laura, Stuart Bloom, Anthony W. Segal, et al.. (2020). Incidence and prevalence of inflammatory bowel disease in UK primary care: a population-based cohort study. BMJ Open. 10(7). e036584–e036584. 63 indexed citations
4.
Schiff, Elena, Matthew Frampton, Francesca Semplici, et al.. (2018). Rare coding variant analysis in a large cohort of Ashkenazi Jewish families with inflammatory bowel disease. Human Genetics. 137(9). 723–734. 7 indexed citations
5.
Bloom, Stuart, et al.. (2018). The Sister Mary Joseph nodule. British Journal of Hospital Medicine. 79(2). C27–C29. 5 indexed citations
6.
Dodd, Susanna, Stuart Bloom, Fraser Cummings, et al.. (2017). PTH-096 Improved outcomes of emergency admission for ulcerative colitis (uc) in england over the last decade: a ten year analysis of routine nhs data. Gut. 66. A254.1–A254. 1 indexed citations
7.
Arnott, Ian, Craig Mowat, Holly Ennis, et al.. (2016). OP026. The TOPPIC Trial: a randomised, double-blind parallel-group trial of mercaptopurine versus placebo to prevent recurrence of Crohn’s disease following surgical resection in 240 patients. Journal of Crohn s and Colitis. 10(suppl 1). S21–S22. 2 indexed citations
8.
Chavda, Selina J & Stuart Bloom. (2015). Ascites. British Journal of Hospital Medicine. 76(2). C23–C27. 2 indexed citations
9.
Atreya, Raja, Stuart Bloom, Franco Scaldaferri, et al.. (2015). OP015. Multicentre clinical trial with topical administration of the Toll-Like receptor 9 agonist DIMS0150 shows evidence for efficacy in moderate to severe Ulcerative Colitis. Journal of Crohn s and Colitis. 9(suppl 1). S9–S9. 1 indexed citations
10.
11.
O’Donoghue, Diarmuid P., Stuart Bloom, & Ivan S. Coulter. (2013). COLON TARGETED, LOW SYSTEMIC ABSORPTION SOLUBLE CICLOSPORIN IN ULCERATIVE COLITIS. Gut. 62(Suppl 2). A1.3–A2. 4 indexed citations
12.
13.
Brown, Nicholas F., Daniel JB Marks, Philip J Smith, & Stuart Bloom. (2011). Splenomegaly. British Journal of Hospital Medicine. 72(Sup11). M166–M169. 6 indexed citations
14.
Wahed, Mahmood, James Goodhand, Louise Langmead, et al.. (2011). Anxiety and psychological stress in acute severe ulcerative colitis: prevalence and effect on outcome. Gut. 60(Suppl 1). A222.1–A222. 1 indexed citations
15.
16.
Smith, Andrew, Farooq Rahman, Bu Hayee, et al.. (2009). Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease. The Journal of Experimental Medicine. 206(9). 1883–1897. 315 indexed citations
17.
Hill, Ciaran Scott, et al.. (2008). A rare case of vomiting: fourth ventricular B-cell lymphoma. Journal of Neuro-Oncology. 93(2). 261–262. 19 indexed citations
18.
Bloom, Stuart, K A Fleming, & Roger W. Chapman. (1995). Adhesion molecule expression in primary sclerosing cholangitis and primary biliary cirrhosis.. Gut. 36(4). 604–609. 46 indexed citations
19.
Bloom, Stuart, A Heryet, K A Fleming, & Roger W. Chapman. (1993). Inappropriate expression of blood group antigens on biliary and colonic epithelia in primary sclerosing cholangitis.. Gut. 34(7). 977–983. 11 indexed citations
20.
Bloom, Stuart, D Lindsell, N.G. Ryley, & Roger W. Chapman. (1990). CORRELATION BETWEEN HEPATIC ULTRASOUND AND HISTOLOGY IN 102 PATIENTS. Hepatology. 12. 978–978. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kim L. Isaacs Breakdown of academic impact, for papers by Graham Radford‐Smith Breakdown of academic impact, for papers by Dominik Bettenworth Breakdown of academic impact, for papers by Christian Maaser Breakdown of academic impact, for papers by Mark Löwenberg Breakdown of academic impact, for papers by Eugeni Domènech Breakdown of academic impact, for papers by Charlie W. Lees Breakdown of academic impact, for papers by Mariangela Allocca Breakdown of academic impact, for papers by Timothy R. Orchard Breakdown of academic impact, for papers by Gwo‐Tzer Ho
Rankless by CCL
2026